Literature DB >> 20418539

Rapid reverse phase-HPLC assay of HMG-CoA reductase activity.

Matteo Mozzicafreddo1, Massimiliano Cuccioloni, Anna Maria Eleuteri, Mauro Angeletti.   

Abstract

Radioisotope-based and mass spectrometry coupled to chromatographic techniques are the conventional methods for monitoring HMG-CoA reductase (HMGR) activity. Irrespective of offering adequate sensitivity, these methods are often cumbersome and time-consuming, requiring the handling of radiolabeled chemicals or elaborate ad-hoc derivatizing procedures. We propose a rapid and versatile reverse phase-HPLC method for assaying HMGR activity capable of monitoring the levels of both substrates (HMG-CoA and NADPH) and products (CoA, mevalonate, and NADP(+)) in a single 20 min run with no pretreatment required. The linear dynamic range was 10-26 pmol for HMG-CoA, 7-27 nmol for NADPH, 0.5-40 pmol for CoA and mevalonate, and 2-27 nmol for NADP(+), and limit of detection values were 2.67 pmol, 2.77 nmol, 0.27 pmol, and 1.3 nmol, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418539      PMCID: PMC2903805          DOI: 10.1194/jlr.D006155

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  Structural mechanism for statin inhibition of HMG-CoA reductase.

Authors:  E S Istvan; J Deisenhofer
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

2.  Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low density lipoprotein receptor.

Authors:  M G Caruso; M Notarnicola; M Santillo; A Cavallini; A Di Leo
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

3.  Highly sensitive assay of HMG-CoA reductase activity by LC-ESI-MS/MS.

Authors:  Akira Honda; Yuji Mizokami; Yasushi Matsuzaki; Tadashi Ikegami; Mikio Doy; Hiroshi Miyazaki
Journal:  J Lipid Res       Date:  2007-02-01       Impact factor: 5.922

4.  Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.

Authors:  Marjo Jauhiainen; Hannu Mönkkönen; Johanna Räikkönen; Jukka Mönkkönen; Seppo Auriola
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-14       Impact factor: 3.205

5.  A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis.

Authors:  L B Nguyen; S Shefer; G Salen; G C Ness; G S Tint; F G Zaki; I Rani
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

6.  Analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors using liquid chromatography-electrospray mass spectrometry.

Authors:  E J Park; D Lee; Y G Shin; D D Lantvit; R B van Breemen; A D Kinghorn; J M Pezzuto
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-04-25

7.  Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.

Authors:  E S Istvan; M Palnitkar; S K Buchanan; J Deisenhofer
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

8.  Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect.

Authors:  G S Saini; T A Wani; A Gautam; B Varshney; T Ahmed; K S Rajan; K K Pillai; J K Paliwal
Journal:  J Lipid Res       Date:  2006-07-21       Impact factor: 5.922

9.  Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.

Authors:  Zhihong Yang; Hang Xiao; Huanyu Jin; Phillip T Koo; Dorothea J Tsang; Chung S Yang
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

10.  Assay of 3-hydroxy-3-methylglutaryl CoA reductase activity using anionic-exchange column chromatography.

Authors:  K K Ong; H T Khor; D T Tan
Journal:  Anal Biochem       Date:  1991-08-01       Impact factor: 3.365

View more
  3 in total

1.  Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.

Authors:  Massimiliano Cuccioloni; Matteo Mozzicafreddo; Michele Spina; Chi Nhan Tran; Maurizio Falconi; Anna Maria Eleuteri; Mauro Angeletti
Journal:  J Lipid Res       Date:  2011-02-25       Impact factor: 5.922

2.  Optimization, validation and application of an assay for the activity of HMG-CoA reductase in vitro by LC-MS/MS.

Authors:  Jing Wang; Ji-Ye Sun; Chun-Jie Sha; Yu-Feng Shao; Yan-Hong Liu; You-Xin Li; Zhen-Wen Duan; Wan-Hui Liu
Journal:  J Pharm Anal       Date:  2015-07-03

3.  Bioactivities of Centaurium erythraea (Gentianaceae) Decoctions: Antioxidant Activity, Enzyme Inhibition and Docking Studies.

Authors:  Laura Guedes; Pedro B P S Reis; Miguel Machuqueiro; Asma Ressaissi; Rita Pacheco; Maria Luísa Serralheiro
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.